A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

NCT05999994 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms
Child
Adolescent

Interventions

DRUG: Ramucirumab
DRUG: Cyclophosphamide
DRUG: Vinorelbine
DRUG: Gemcitabine
DRUG: Docetaxel
DRUG: Abemaciclib
DRUG: Irinotecan
DRUG: Temozolomide

Sponsor

Eli Lilly and Company